Exceptional stroke-like episodes in a patient with type I autosomal angioedema

Neurology

Volumn 78, Issue 8, 2012, Pages 598-599

  Bonnaud, I ^a   Rouaud, V ^a   Guyot, M ^a   Debiais, S ^a   Saudeau, D ^a   De Toffol, B ^a   Farber, C M ^b  

^a UNIVERSITÉ DE TOURS   (France)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DRUG MEGADOSE; DYSLIPIDEMIA; ERYTHEMA; HUMAN; MALE; MOTOR DYSFUNCTION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSORY DYSFUNCTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 84858143605     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318247ca58     Document Type: Article

References (7)

1. Osler W. Hereditary angioneurotic edema. Am J Med Sci 1888;95:362-367.
2. Zuraw BL. Hereditary angioedema. N Engl J Med 2008; 359:1027-1036.
3. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006;119:267-274. (Pubitemid 43255068)
4. Krause KH, Rentrop U, Mehregan U. Cerebral manifestations in angioneurotic edema. J Neurol Sci 1979;42:429-435. (Pubitemid 9188021)
5. Davis AE III, Mejia LP, Lu F. Biological activities of C1 inhibitor. Mol Immunol 2008;45:4057-4063.
6. Davis AE III. New treatments addressing the pathophysiology of hereditary angioedema. Clin Mol Allergy 2008;6:2-9.
7. Gesuete R, Storini C, Fantin A, et al. Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol 2009;66: 332-342.